Matches in DBpedia 2016-04 for { ?s ?p "BMS-564,929 is an investigational selective androgen receptor modulator, which is being developed by Bristol-Myers Squibb for treatment of the symptoms of age-related decline in androgen levels in men (\"andropause\"). These symptoms may include depression, loss of muscle mass and strength, reduction in libido and osteoporosis."@en }
Showing triples 1 to 1 of
1
with 100 triples per page.
- BMS-564,929 comment "BMS-564,929 is an investigational selective androgen receptor modulator, which is being developed by Bristol-Myers Squibb for treatment of the symptoms of age-related decline in androgen levels in men (\"andropause\"). These symptoms may include depression, loss of muscle mass and strength, reduction in libido and osteoporosis.".